123 related articles for article (PubMed ID: 3398698)
1. Presynaptic inhibition of excitatory input from the substantia nigra to caudate nucleus neurons by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392).
Sasa M; Ohno Y; Takaori S
Life Sci; 1988; 43(3):263-9. PubMed ID: 3398698
[TBL] [Abstract][Full Text] [Related]
2. D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area.
Momiyama T; Sasa M; Takaori S
Life Sci; 1990; 47(9):761-9. PubMed ID: 1977066
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons.
Ohno Y; Sasa M; Takaori S
Life Sci; 1987 May; 40(19):1937-45. PubMed ID: 3553819
[TBL] [Abstract][Full Text] [Related]
4. Excitation by talipexole, a dopamine D2 agonist, of caudate nucleus neurons activated by nigral stimulation.
Todo N; Momiyama T; Amano T; Kohno Y; Sasa M
Life Sci; 1994; 54(14):957-66. PubMed ID: 7908115
[TBL] [Abstract][Full Text] [Related]
5. Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation.
Ohno Y; Sasa M; Takaori S
Life Sci; 1986 May; 38(20):1867-73. PubMed ID: 2939313
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D-2 receptor-mediated excitation of caudate nucleus neurons from the substantia nigra.
Ohno Y; Sasa M; Takaori S
Life Sci; 1985 Oct; 37(16):1515-21. PubMed ID: 3900614
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.
Momiyama T; Amano T; Todo N; Sasa M
Eur J Pharmacol; 1996 Aug; 310(1):1-8. PubMed ID: 8880060
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra.
Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 1999 Sep; 146(2):139-43. PubMed ID: 10525748
[TBL] [Abstract][Full Text] [Related]
9. Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens.
Amano T; Matsubayashi H; Momiyama T; Ishihara K; Todo N; Sasa M
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):105-16. PubMed ID: 7708924
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor-mediated inhibition of dopaminergic excitatory input to caudate neurons from the substantia nigra.
Nabatame H; Sasa M; Takaori S; Kameyama M
Jpn J Pharmacol; 1988 Apr; 46(4):387-95. PubMed ID: 3404769
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic inhibition from substantia nigra of caudate neurons activated by cortical stimulation.
Fujimoto S; Sasa M; Takaori S
Jpn J Pharmacol; 1981 Dec; 31(6):1037-42. PubMed ID: 7334727
[TBL] [Abstract][Full Text] [Related]
12. Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons.
Matsubayashi H; Amano T; Hongjing Y; Kohno Y; Sasa M
Psychopharmacology (Berl); 1995 Aug; 120(4):369-75. PubMed ID: 8539316
[TBL] [Abstract][Full Text] [Related]
13. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
[TBL] [Abstract][Full Text] [Related]
14. Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release.
Yu H; Matsubayashi H; Amano T; Cai J; Sasa M
Brain Res; 2000 Jul; 872(1-2):223-6. PubMed ID: 10924698
[TBL] [Abstract][Full Text] [Related]
15. Inhibition from locus coeruleus of caudate neurons activated by nigral stimulation.
Fujimoto S; Sasa M; Takaori S
Brain Res Bull; 1981 Mar; 6(3):267-74. PubMed ID: 7225906
[TBL] [Abstract][Full Text] [Related]
16. Effect of 7-(3-[4-(2,3-dimethylphenyl)piperazinyl]propoxy)- 2(1H)-quinolinone (OPC-4392), a newly synthesized agonist for presynaptic dopamine D2 receptor, on tyrosine hydroxylation in rat striatal slices.
Kiuchi K; Hirata Y; Minami M; Nagatsu T
Life Sci; 1988; 42(3):343-9. PubMed ID: 2892110
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
Hirose A; Sasa M; Ohno Y; Takaori S
Jpn J Pharmacol; 1988 Dec; 48(4):435-40. PubMed ID: 2907593
[TBL] [Abstract][Full Text] [Related]
18. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S
J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
Waszczak BL
Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
[TBL] [Abstract][Full Text] [Related]
20. Decreased sensitivity of caudatal neurons to microiontophoretic dopamine in dopamine-depleted caudate nucleus.
Norcross K; Spehlmann R
Brain Res; 1978 Nov; 156(1):175-80. PubMed ID: 698832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
